Palivizumab-resistant respiratory syncytial virus was isolated from an infant treated with palivizumab. A stable mutation at codon 276 led to a nearly complete resistance to palivizumab. Additional studies revealed a second mutation at codon 272. Further passage of the virus led to a complete loss of binding of palivizumab. © 2010 by the Infectious Diseases Society of America. All rights reserved.
CITATION STYLE
Adams, O., Bonzel, L., Kovacevic, A., Mayatepek, E., Hoehn, T., & Voge, M. (2010). Palivizumab-resistant human respiratory syncytial virus infection in infancy. Clinical Infectious Diseases, 51(2), 185–188. https://doi.org/10.1086/653534
Mendeley helps you to discover research relevant for your work.